CVS - CVS Health Corporation
NEXT EARNINGS:
May 7, 2026
EPS Est: $2.23
|
Rev Est: $95.9B
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$94.92
DETAILS
HIGH:
$103.00
LOW:
$90.00
MEDIAN:
$93.00
CONSENSUS:
$94.92
UPSIDE:
27.96%
Market Cap:
94.37B
Volume:
12,171,727
Avg Volume:
8,359,475
52 Week Range:
58.35-85.15
Sector:
Healthcare
Industry:
Medical - Healthcare Plans
Beta:
0.50
Last Dividend:
$2.66
Exchange:
NYSE
Country:
US
Employees:
219,000
IPO Date:
1996-11-20
EPS (TTM):
1.40
P/E Ratio:
56.87
Revenue (TTM):
402.07B
Total Assets:
261.06B
Total Debt:
93.59B
Cash & Equiv:
8.51B
Rev Growth (5Y):
8.4%
EPS Growth (5Y):
-23.9%
FCF Growth (5Y):
-10.3%
ROCE:
3.0%
Debt/Equity:
1.24
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-10 | $1.09 | $1.00 | +9.0% | $105.7B | $103.7B | +1.9% |
| 2025-10-29 | $1.60 | $1.37 | +16.8% | $102.9B | $98.8B | +4.1% |
| 2025-07-31 | $1.81 | $1.46 | +24.0% | $98.9B | $94.5B | +4.6% |
| 2025-05-01 | $2.25 | $1.70 | +32.4% | $94.6B | $93.7B | +1.0% |
| 2025-02-12 | $1.19 | $0.91 | +30.2% | $97.7B | $97.1B | +0.6% |
| 2024-11-06 | $1.09 | $1.44 | -24.3% | $95.4B | $92.7B | +2.9% |
| 2024-08-07 | $1.83 | $1.73 | +5.8% | $91.2B | $91.4B | -0.2% |
| 2024-05-01 | $1.31 | $1.70 | -22.9% | $88.4B | $89.3B | -1.0% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 402.07B | 372.81B | 357.78B | 322.47B | 292.11B | 268.71B | 256.78B | 194.58B | 184.79B | 177.55B | 153.29B | 139.37B |
| Net Income | 1.77B | 4.61B | 8.34B | 4.31B | 8.00B | 7.18B | 6.63B | (594.00M) | 6.62B | 5.32B | 5.24B | 4.64B |
| EPS | 1.40 | 3.66 | 6.49 | 3.29 | 6.00 | 5.48 | 5.10 | -0.57 | 6.47 | 4.93 | 4.66 | 3.98 |
| Total Assets | 261.06B | 253.22B | 249.73B | 228.28B | 233.00B | 230.72B | 222.45B | 196.46B | 95.13B | 94.46B | 92.44B | 74.19B |
| Total Debt | 93.59B | 82.92B | 79.39B | 70.73B | 76.00B | 85.04B | 89.00B | 73.43B | 27.00B | 27.53B | 27.46B | 12.89B |
| Cash & Equivalents | 8.51B | 8.59B | 8.20B | 12.95B | 9.41B | 7.85B | 5.68B | 4.06B | 1.70B | 3.37B | 2.46B | 2.48B |
| Operating Cash Flow | 10.64B | 9.11B | 13.43B | 16.18B | 18.27B | 15.87B | 12.85B | 8.87B | 8.01B | 10.14B | 8.54B | 8.14B |
| Free Cash Flow | 7.81B | 6.33B | 10.39B | 13.45B | 15.74B | 13.43B | 10.39B | 6.83B | 6.09B | 7.92B | 6.17B | 6.00B |
| FCF per Share | 6.16 | 5.02 | 8.09 | 10.25 | 11.94 | 10.26 | 7.99 | 6.54 | 5.97 | 7.38 | 5.52 | 5.17 |
| Book Value | 75.21B | 75.56B | 76.46B | 71.47B | 75.08B | 69.39B | 63.86B | 58.23B | 37.69B | 36.83B | 37.20B | 37.96B |
| Cash & ST Investments | 10.66B | 10.99B | 11.46B | 15.72B | 12.53B | 10.85B | 8.06B | 6.58B | 1.81B | 3.46B | 2.55B | 2.52B |
| ROC Equity | 0.02 | 0.06 | 0.11 | 0.06 | 0.11 | 0.10 | 0.10 | -0.01 | 0.18 | 0.14 | 0.14 | 0.12 |